(99 days)
No
The description focuses on the material properties and fabrication process of a dental ceramic, with no mention of AI or ML.
No.
The device is a material (ceramic) used for fabricating dental restorations and bridges, which is not considered a therapeutic device as it does not actively treat or prevent disease but rather replaces or restores anatomical function.
No
The device is a material used for the fabrication of dental restorations (veneers, crowns, bridges), not for diagnosing medical conditions. Its purpose is to create physical dental prosthetics.
No
The device description clearly states it is a "high-strength zirconia-reinforced lithium silicate glass ceramic material" used for fabricating dental restorations, indicating it is a physical material, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the creation of dental restorations (veneers, inlays, onlays, crowns, bridges). This is a therapeutic and restorative purpose, not a diagnostic one.
- Device Description: The device is a material used in a dental lab to fabricate these restorations. It's a physical material, not a test or assay performed on biological samples.
- Lack of Diagnostic Elements: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific markers, or providing information for diagnosis.
- Performance Studies: The performance studies focus on physical properties and biocompatibility of the material, which are relevant to its use as a dental restorative material, not a diagnostic test.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.
N/A
Intended Use / Indications for Use
CELTRA Press is an all-ceramic system for the creation of Occlusal veneers Thin veneers Veneers Inlays Onlays Crowns in the anterior and posterior region 3-unit bridges in the anterior and posterior region 3-unit bridges in the premolar region up to the second premolar as the terminal abutment Crown, splinted crown or 3 unit bridge up to the second premolar placed on top of an implant abutment.
Product codes (comma separated list FDA assigned to the subject device)
EIH
Device Description
CELTRA Press is a high-strength zirconia-reinforced lithium silicate glass ceramic material that can be used for the fabrication of highly aesthetic all-ceramic restorations by using the hot-pressing technique in dental labs. The homogeneous, industrially produced ingots are available in both high and low translucency for full-contour application. They are pressing furnaces using press investments material which do not form surface reaction layer to obtain tooth-colored, highly aesthetic, all-ceramic restorations. Subsequently, CELTRA Press may be veneered, stained and/or glazed with compatible CELTRA Press veneering porcelains.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
anterior and posterior region, premolar region
Indicated Patient Age Range
Not Found
Intended User / Care Setting
dental labs
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Physical Properties: In accordance with ISO 6872:2015 (Dentistry - Ceramic materials), the product must meet the requirements for flexural strength, chemical solubility, coefficient of thermal expansion, and radioactivity. Both CELTRA Press and predicate IPS e.max Press and IPS e.max Press Multi (K120134) meet the requirements of the applicable Class. The performance of CELTRA Press meets the requirements of the non-clinical bench testing conducted to support substantial equivalence.
Toxicological Testing: Testing according to ISO 10993-1, 10993-5 and 10993-18 (Biological evaluation of medical devices) was completed to characterize the biocompatibility of CELTRA Press. Results of the testing conducted in accordance with ISO standard support the biocompatibility of CELTRA Press. CELTRA Press veneering porcelains (accessory) were compared to reference device, Quattro Porcelain System (K091706) for biocompatibility purposes.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.6660 Porcelain powder for clinical use.
(a)
Identification. Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 16, 2016
Dentsply Sirona Helen Lewis Director Corporate Regulatory Affairs 221 West Philadelphia Street, Suite 60 York, Pennsylvania 17404
Re: K161269
Trade/Device Name: CELTRA Press Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain powder for clinical use Regulatory Class: Class II Product Code: EIH Dated: July 5, 2016 Received: July 6, 2016
Dear Ms. Helen Lewis:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
1
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Susan Runno DDS, MA
Tina Kiang, Ph.D. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
510(k) Number (if known)
Device Name CELTRA Press
Indications for Use (Describe) CELTRA Press is an all-ceramic system for the creation of Occlusal veneers Thin veneers Veneers Inlays Onlays Crowns in the anterior and posterior region 3-unit bridges in the anterior and posterior region 3-unit bridges in the premolar region up to the second premolar as the terminal abutment Crown, splinted crown or 3 unit bridge up to the second premolar placed on top of an implant abutment.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW .
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Dentsplv Sirona 221 West Philadelphia Street Suite 60 York, PA 17404
Image /page/3/Picture/1 description: The image shows the logo for Dentsply Sirona. The logo consists of a stylized leaf-like shape on the left, followed by the words "Dentsply" and "Sirona" stacked on top of each other on the right. The text and the leaf are in a gray color.
SECTION 5. 510(k) SUMMARY for CELTRA Press
Submitter Information:
Dentsply Sirona 221 West Philadelphia Street Suite 60 York, PA 17404
| Contact Person: | Helen Lewis |
|---|---|
| Telephone Number: | 717-487-1332 |
| Fax Number: | 717-849-4343 |
Date Prepared: 24 June 2016
Device Name:
| ● | Proprietary Name: | CELTRA Press |
|---|---|---|
| ● | Common Name: | All-ceramic system |
| ● | Classification Name: | Porcelain powder for clinical use |
| ● | CFR Number: | 21 C.F.R. 872.6660 |
| ● | Device Class: | II |
| ● | Product Code: | EIH |
Predicate Device:
| Predicate Device Name | 510(k) | Company Name |
|---|---|---|
| IPS e.max Press and IPS e.max Press Multi | K120134 | Ivoclar Vivadent AG |
| Reference Device for Biocompatibility | ||
| Quattro Porcelain System | K091706 | DENTSPLY Prosthetics |
Description of Device:
CELTRA Press is a high-strength zirconia-reinforced lithium silicate glass ceramic material that can be used for the fabrication of highly aesthetic all-ceramic restorations by using the hot-pressing technique in dental labs. The homogeneous, industrially produced ingots are available in both high and low translucency for full-contour application. They are pressing furnaces using press investments material which do not form surface reaction layer to obtain tooth-colored, highly aesthetic, all-ceramic restorations. Subsequently, CELTRA Press may be veneered, stained and/or glazed with compatible CELTRA Press veneering porcelains.
4
Indications for Use:
CELTRA Press is an all-ceramic system for the creation of Occlusal veneers Thin veneers Veneers Inlays Onlays Crowns in the anterior and posterior region 3-unit bridges in the anterior and posterior region 3-unit bridges in the premolar region up to the second premolar as the terminal abutment Crown, splinted crown or 3 unit bridge up to the second premolar placed on top of an implant abutment.
Substantial Equivalence:
The proposed CELTRA Press has the similar indications for use as the predicate IPS e.max Press and IPS e.max Press Multi (K120134) with the exception of an indication for 3-unit bridges in the posterior region. The proposed CELTRA Press meets the requirement of flexural strength for this indication in accordance with ISO 6872:2015 (Dentistry - Ceramic materials).
| Proposed Device | Predicate Device | Differences |
|---|---|---|
| CELTRA Press system | IPS e.max Press and IPS | |
| e.max Press Multi, K120134 | ||
| Indications for Use: | ||
| CELTRA Press is an all- | ||
| ceramic system for the creation | ||
| of | ||
| Occlusal veneers | ||
| Thin veneers | ||
| Veneers | ||
| Inlays | ||
| Onlays | ||
| Crowns in the anterior and | ||
| posterior region | ||
| 3-unit bridges in the anterior | ||
| and posterior region | ||
| 3-unit bridges in the premolar | ||
| region up to the second | ||
| premolar as the terminal | ||
| abutment | ||
| Crown, splinted crown or 3 unit | ||
| bridge up to the second | ||
| premolar placed on top of an | ||
| implant abutment. | Indications for Use: | |
| IPS e.max Press and IPS e.max | ||
| Press Multi is an all-ceramic | ||
| system for the creation of | ||
| Occlusal veneers | ||
| Thin Veneers | ||
| Veneers | ||
| Inlays | ||
| Onlays | ||
| Crowns in the anterior and | ||
| posterior region | ||
| 3-unit bridges in the anterior | ||
| region | ||
| 3-unit bridges in the premolar | ||
| region up to the second | ||
| premolar as the terminal | ||
| abutment | ||
| Crown, splinted crown or 3 unit | ||
| bridge up to the second | ||
| premolar placed on top of an | ||
| implant abutment. | The proposed device | |
| CELTRA Press is indicated | ||
| for 3-unit posterior bridges | ||
| while the predicate IPS | ||
| e.max Press and IPS | ||
| e.max Press Multi, | ||
| K120134 is not indicated | ||
| for this use based on its | ||
| ISO 6872 standard | ||
| classification. |
Technological Characteristics:
The proposed CELTRA Press was classified and tested in accordance with ISO 6872:2015 (Dentistry – Ceramic materials). CELTRA Press classification and clinical usage is noted below: Type II: All other forms of ceramic products
Class 4a: Monolithic ceramic for three-unit prostheses involving molar restoration Class 4b: Partially or fully covered substructure for three-unit prostheses involving molar restoration
5
| Physical
Properties
ISO 6872 | Proposed Device
CELTRA Press | Predicate
Device
IPS e.max
Press and IPS
e.max Press
Multi, K120134 | Differences |
|----------------------------------------------------------------------------------------------------------------------------------------|---------------------------------|------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Type and
Classification
Flexural Strength
Chemical Solubility
Coefficient of
Thermal Expansion,
CTE
Radioactivity | Conforms to ISO
6872 | Conforms to
ISO 6872 | The proposed device CELTRA
Press is a Type II class 4 device
which requires a minimum mean
flexural strength of 500MPa
while the predicate IPS e.max
Press and IPS e.max Press
Multi, K120134 is a Type II class
3 devices based on its ISO 6872
standard classification. |
The strength of the proposed CELTRA Press meets the reguirement for Type II Class 4 (materials with a minimum mean flexural strength of 500 MPa), which by definition includes three unit prostheses.
Non-Clinical Performance Data:
Physical Properties:
In accordance with ISO 6872:2015 (Dentistry - Ceramic materials), the product must meet the requirements for flexural strength, chemical solubility, coefficient of thermal expansion, and radioactivity. Both CELTRA Press and predicate IPS e.max Press and IPS e.max Press Multi (K120134) meet the requirements of the applicable Class, as detailed in Table under Technological The performance of CELTRA Press meets the requirements of the non-clinical Characteristics. bench testing conducted to support substantial equivalence.
Toxicological Testing;
Testing according to ISO 10993-1, 10993-5 and 10993-18 (Biological evaluation of medical devices) was completed to characterize the biocompatibility of CELTRA Press. Results of the testing conducted in accordance with ISO standard support the biocompatibility of CELTRA Press. CELTRA Press veneering porcelains (accessory) were compared to reference device, Quattro Porcelain System (K091706) for biocompatibility purposes.
Clinical Performance Data.
Not applicable. No data from human clinical studies has been included to support the substantial equivalence of the CELTRA Press.
Conclusion Regarding Substantial Equivalence
CELTRA Press supports substantial equivalence to the predicate IPS e.max Press and IPS e.max Press Multi cleared under premarket notification K120134 because:
- It has the similar intended use as the predicate ●
- . Has similar technological characteristics as the predicate, with the exception of flexural strength. CELTRA Press meets the requirement of flexural strength for Type II, Class 4 materials.